NDC 73521-030

Tyrvaya

Varenicline

Tyrvaya is a Nasal Spray in the Human Prescription Drug category. It is labeled and distributed by Oyster Point Pharma. The primary component is Varenicline.

Product ID73521-030_1b36343e-1b34-4a54-a43f-4b53ad3edc80
NDC73521-030
Product TypeHuman Prescription Drug
Proprietary NameTyrvaya
Generic NameVarenicline
Dosage FormSpray
Route of AdministrationNASAL
Marketing Start Date2021-10-20
Marketing CategoryNDA /
Application NumberNDA213978
Labeler NameOyster Point Pharma
Substance NameVARENICLINE
Active Ingredient Strength0 mg/.05mL
Pharm ClassesCholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73521-030-02

2 BOTTLE, PUMP in 1 CARTON (73521-030-02) > 4.2 mL in 1 BOTTLE, PUMP
Marketing Start Date2021-10-20
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tyrvaya" or generic name "Varenicline"

NDCBrand NameGeneric Name
73521-030Tyrvayavarenicline
60505-4765APO-VARENICLINEVARENICLINE
60505-4766APO-VARENICLINEVARENICLINE
60505-4767APO-VARENICLINEVARENICLINE

Trademark Results [Tyrvaya]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TYRVAYA
TYRVAYA
88873736 not registered Live/Pending
Oyster Point Pharma, Inc.
2020-04-15
TYRVAYA
TYRVAYA
88791700 not registered Live/Pending
Oyster Point Pharma, Inc.
2020-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.